55.54%| YTD | 1Yr | 3Yr | 5Yr | 10Yr | |
| Fund | 55.54 | 66.07 | 5.41 | 9.46 | 2.04 |
| Classification | 41.84 | 65.08 | -3.82 | 5.59 | 3.12 |
| Index (S&P 500) | 25.20 | 41.80 | -5.60 | 0.80 | -0.60 |
| % Rank in Class (1-best,100=worst) | 14 | 49 | 2 | 4 | 64 |
| Investment Objective: | International |
|---|---|
| Net Assets ($Mil) | 13.50 |
| Inception Date: | 6/8/99 |
| Manager Name, Tenure | Gadi Beer, 2003 |
| Expense Ratio: | 3.24% |
|
Sales Charge:
Load Type:
|
No Load 0.00% 0.00% |
| Company Name | Symbol | % Net Assets |
|---|---|---|
| Teva Pharmaceutical Industries Ltd | TEVA | 15.77 |
| Icl-israel Chemicals Ltd | ISCHF | 11.52 |
| Fidelity Instl Money Market Portfolio;select | NA | 9.09 |
| Check Point Software Technologies Ltd | CHKP | 5.52 |
| Israel Corporation Ltd | NA | 5.20 |
| Bezeq | BZQIF | 4.99 |
| Amdocs Ltd | DOX | 4.61 |
| Bank Leumi Le-israel Bm | NA | 4.52 |
| Bank Hapoalim Bm | BKHPF | 4.40 |
| Partner Comm | PTNR | 3.95 |
| % of Total Holdings | 69.57 | |